GUMM - Eliminate the Common Cold Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: pz who wrote (4313)	4/30/2003 1:19:41 AM
From: Mike M	of 5582

From an investor's point of view in the short run you're probably right Paul... However, I am sure that MTXX is vying for market as well as brand recognition for Zicam and some of their new products. They are also going for more shelf space for Zicam et al... I also suspect that they see increased sales as a win in hopes that they don't have to spend as much on advertising/sale next season. Who knows if it works out in the long run. MTXX may still be trying to figure out how much advertising is enough (or too much) during each season of the year. I doubt MTXX will be spending very much money on advertising the next two quarters for the existing seasonal products... I don't know anything about the two new products to be released this year that Dan mentioned in his post.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next